Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term?

American Journal of Obstetrics and Gynecology
J R BartonB M Sibai

Abstract

Our purpose was to compare maternal and perinatal outcomes of mature women with those in younger women with pregnancies complicated by mild hypertension remote from term. A matched cohort design was used. A total of 379 mature pregnant women (> or = 35 years old) with mild hypertension remote from term were matched for race, gestational age, and proteinuria status at enrollment with 379 adult controls aged 20 to 30 years also with mild hypertension remote from term. All were enrolled in an outpatient management program that included automated blood pressure measurements and daily assessment of weight, proteinuria, and fetal movement. The mean gestational age at enrollment was 32.7 +/- 3.0 weeks for both groups (range 24 to 36 weeks). By matching 20.6% of patients in each group had > or = 1+ proteinuria on urinary dipstick at enrollment, and 77.3% of patients in each group were white. Chronic hypertension was more common in the mature group (22.4% vs 14.5%, p = 0.007). The mean gestational age at delivery (37.2 +/- 2.3 vs 37.2 +/- 2.2 weeks), the mean pregnancy prolongation (28.1 +/- 21.0 vs 28.4 +/- 22.0 days), and the mean birth weights (2864 +/- 770 vs 2906 +/- 788 gm) were similar between the mature and younger groups (all p...Continue Reading

References

Mar 8, 1990·The New England Journal of Medicine·G S BerkowitzR L Berkowitz
Jan 1, 1988·American Journal of Obstetrics and Gynecology·K S LeeL M Gartner
Feb 1, 1987·American Journal of Obstetrics and Gynecology·M MartelE Hamilton
May 1, 1985·American Journal of Obstetrics and Gynecology·D S KirzR K Freeman
Jun 1, 1995·American Journal of Obstetrics and Gynecology·R A Bobrowski, S F Bottoms
Mar 1, 1994·American Journal of Obstetrics and Gynecology·J R BartonB M Sibai
Apr 1, 1994·British Journal of Obstetrics and Gynaecology·E G RaymondJ L Kiely
Dec 1, 1995·American Journal of Obstetrics and Gynecology·J R BartonB M Sibai
Mar 1, 1996·American Journal of Obstetrics and Gynecology·D A MillerR H Paul

❮ Previous
Next ❯

Citations

Jan 24, 2007·Maternal and Child Health Journal·Suzanne ToughChristine Newburn-Cook
Jun 21, 2007·Health Care for Women International·M Carolan, S Nelson
Sep 9, 2006·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Karen BenziesChristine Newburn-Cook
Feb 7, 2003·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Mary Carolan
Nov 23, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ilse DelbaereMarleen Temmerman
Jan 26, 2002·American Journal of Obstetrics and Gynecology·Alan BuchbinderUNKNOWN National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units
Apr 17, 2001·American Journal of Obstetrics and Gynecology·J R BartonB M Sibai
Mar 9, 2006·American Journal of Obstetrics and Gynecology·Kjersti M Aagaard-TilleryMichael W Varner
Nov 5, 1999·Preventive Medicine·H S ScholzE Petru
May 21, 2015·Einstein·Evandro Eduardo CanhaçoReginaldo Guedes Coelho Lopes
Jun 5, 2002·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·J R BartonB M Sibai
Aug 19, 1999·Clinical Obstetrics and Gynecology·J R BartonB M Sibai
Sep 22, 1998·Clinical Obstetrics and Gynecology·A G Witlin, B M Sibai
Aug 22, 2001·Obstetrics and Gynecology Clinics of North America·J C Livingston, B M Sibai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.